Time-Resolved Profiling Reveals ATF3 as a Novel Mediator of Endocrine Resistance in Breast Cancer.
Borgoni S, Sofyalı E, Soleimani M, Wilhelm H, Müller-Decker K, Will R, Noronha A, Beumers L, Verschure PJ, Yarden Y, Magnani L, van Kampen AHC, Moerland PD, Wiemann S.
Borgoni S, et al. Among authors: wiemann s.
Cancers (Basel). 2020 Oct 11;12(10):2918. doi: 10.3390/cancers12102918.
Cancers (Basel). 2020.
PMID: 33050633
Free PMC article.